Article preview from "The Gray Sheet"- May 23, 2011
The European Society of Cardiology says medical device oversight in Europe is not sufficient, and is calling for a single European regulatory body to oversee product evaluation and approval.
Cardiologist Group Calls For Centralized Device Oversight In Europe
Article preview from "The Gray Sheet"- May 23, 2011
The European Society of Cardiology says medical device oversight in Europe is not sufficient, and is calling for a single European regulatory body to oversee product evaluation and approval.
The prominent cardiology group offered proposals for reforming European device oversight in an article published May 14 in the European Heart Journal.
The creation of a single regulatory authority for devices would be "the most efficient way" of providing uniform and higher standards for device reviews in Europe, the cardiologists write.
It could be either a division within the existing European Medicines Agency or an entirely new body.
The group presented some dozen recommendations, reached at a European Society of Cardiology policy conference January 27-28 that included experts from the European Commission, FDA, the American College of Cardiology and device industry trade groups.
Continued...
To read this article in its entirety, Purchase now as a PDF and receive it immediately via email. Or get it FREE when you subscribe to Medtech Insight Newsletter.
About Medtech Insight
Medtech Insight newsletter provides insights into the technology and market developments (devices, instrumentation, biomaterials, gene therapy, tissue engineering, etc.) impacting a wide range of surgical and non-surgical clinical practices.
Plus:
To find out about more about more about Elsevier Business Intelligence's medical device publications and databases, multi-user access and/or advertising with Medical Devices Today, please contact Kristy Kennedy at (480) 985-9512




.jpg)


Comments